Andrew Hoffman

Andrew Hoffman assumed the deanship of the School of Veterinary Medicine at the University of Pennsylvania in August 2018, after 24 years at Tufts University. Among other roles held at Tufts, he was Director of Equine Sports Medicine, the Lung Function Testing Laboratory, the Stem Cell Laboratory, and the Regenerative Medicine Laboratory. In addition to industry support, his laboratories have been continuously funded through NIH for over 20 years. Hoffman’s work advanced intellectual property and licensing of non-invasive bronchoscopic therapies for emphysema (AeroSeal), home sleep testing methods, inhalers for delivery of medication to large animals (AeroHippus, Trudell), and non-invasive-portable lung function testing devices (Open Pleth, Ambulatory Monitoring). More recently he has developed IP around immunophenotypic biomarkers in cancer and stem cells using extracellular vesicles. Hoffman has extensive experience in the development of cell-based therapies and clinical trials in companion animals. His broad experiences have led to an appreciation for the integral role that veterinarians can play in leading biomedical research, and opportunities for veterinarians to both drive and lead commercial and not-for-profit (i.e. social) entrepreneurship across the biotech, info-tech, agri-tech, and pet-tech spectrum.